Generation Bio Co.
DelistedCIK 1733294fmd_1RPCF58ZZWFTKQGVQ1YJQAE9B0Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2025, 26 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Total revenues | – | – | 0 | 0 | 6 | 20 |
| Research and development | 50 | 59 | 85 | 97 | 94 | 61 |
| Total operating expenses | 62 | 81 | 119 | 141 | 144 | 162 |
| Operating income | (62) | (81) | (119) | (141) | (139) | (142) |
| Other non-operating income (expense) | 1 | 1 | (0) | 5 | 12 | 11 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | (61) | (81) | (119) | (137) | (127) | (132) |
| Net income to common shareholders | (61) | (81) | (119) | (137) | – | – |